Clinical Trial Update: New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer

View source ↗

Summary

A completed clinical trial from the Chinese University of Hong Kong explores a novel approach to assessing drug response in advanced nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Advanced Nasopharyngeal Carcinoma | Status: COMPLETED